PL1879609T3 - Zastosowanie histonu w celach terapeutycznych - Google Patents

Zastosowanie histonu w celach terapeutycznych

Info

Publication number
PL1879609T3
PL1879609T3 PL06742792T PL06742792T PL1879609T3 PL 1879609 T3 PL1879609 T3 PL 1879609T3 PL 06742792 T PL06742792 T PL 06742792T PL 06742792 T PL06742792 T PL 06742792T PL 1879609 T3 PL1879609 T3 PL 1879609T3
Authority
PL
Poland
Prior art keywords
histones
therapeutic purposes
therapeutic
purposes
Prior art date
Application number
PL06742792T
Other languages
English (en)
Inventor
Michael Zeppezauer
Class Reiner
Original Assignee
Symbiotec Ges Zur Forschung Und Entwicklung Auf Dem Gebiet Der Biotechnologie Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbiotec Ges Zur Forschung Und Entwicklung Auf Dem Gebiet Der Biotechnologie Mbh filed Critical Symbiotec Ges Zur Forschung Und Entwicklung Auf Dem Gebiet Der Biotechnologie Mbh
Publication of PL1879609T3 publication Critical patent/PL1879609T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL06742792T 2005-05-10 2006-05-04 Zastosowanie histonu w celach terapeutycznych PL1879609T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005022319A DE102005022319A1 (de) 2005-05-10 2005-05-10 Verwendung von Histonen zu therapeutischen Zwecken
EP06742792.2A EP1879609B1 (de) 2005-05-10 2006-05-04 Verwendung von histonen zu therapeutischen zwecken
PCT/EP2006/004167 WO2006119912A2 (de) 2005-05-10 2006-05-04 Verwendung von histonen zu therapeutischen zwecken

Publications (1)

Publication Number Publication Date
PL1879609T3 true PL1879609T3 (pl) 2014-08-29

Family

ID=37310925

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06742792T PL1879609T3 (pl) 2005-05-10 2006-05-04 Zastosowanie histonu w celach terapeutycznych

Country Status (12)

Country Link
US (3) US20090305966A1 (pl)
EP (1) EP1879609B1 (pl)
JP (2) JP2008540473A (pl)
KR (3) KR20130099207A (pl)
CN (1) CN101171027A (pl)
CA (2) CA2608019C (pl)
DE (1) DE102005022319A1 (pl)
ES (1) ES2461564T3 (pl)
HU (1) HUE027070T2 (pl)
PL (1) PL1879609T3 (pl)
PT (1) PT1879609E (pl)
WO (1) WO2006119912A2 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005022319A1 (de) * 2005-05-10 2006-11-23 Symbiotec Gesellschaft Zur Forschung Und Entwicklung Auf Dem Gebiet Der Biotechnologie Mbh Verwendung von Histonen zu therapeutischen Zwecken

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3580283D1 (de) * 1984-01-12 1990-12-06 Symbiotec Gmbh Biologisch wirksame substanz mit hormonellen eigenschaften, verfahren zu ihrer herstellung und verwendung von histonen fuer medizinische zwecke.
JPH03502582A (ja) * 1988-05-31 1991-06-13 シェリング・バイオテック・コーポレーション 骨髄性白血病の治療方法
DE4000154A1 (de) * 1990-01-04 1991-07-11 Symbiotec Gmbh Chemotherapeutisches mittel, insbesondere zur behandlung von krebserkrankungen
US5571686A (en) * 1994-04-14 1996-11-05 Massachusetts Institute Of Technology Method of using megapoietin for prolonging the survival & viability of platlets
US20030017987A1 (en) * 1997-04-11 2003-01-23 Michael Zeppezauer Therapeutic, prophylactic, and diagnostic agent for cancer, useful for characterizing cancer cells with individual properties
DE19715149A1 (de) 1997-04-11 1998-10-15 Symbiotec Gmbh Krebstherapeutikum und Diagnose zur Charakterisierung von Krebszellen mit individueller Eigenschaft
US6884423B1 (en) * 1998-08-13 2005-04-26 Symbiotec Gmbh Antimicrobial histone H1 compositions, kits, and methods of use thereof
US6468537B1 (en) * 1999-04-28 2002-10-22 The Board Of Trustees Of Northwestern University Localization of major peptide autoepitopes for nucleosome specific T cells of systemic lupus erythematosus
DE10001113A1 (de) * 2000-01-13 2001-07-26 Strathmann Ag & Co Rekombinante Herstellung von humanen Histon 1-Subtypen sowie deren Verwendung für therapeutische Zwecke
US7931897B2 (en) 2001-02-07 2011-04-26 Chugai Seiyaku Kabushiki Kaisha Therapeutic agent for hematopoietic tumors
DE60237756D1 (de) 2001-02-22 2010-11-04 Symbiotec Gmbh Zusammensetzungen zur verhinderung der thrombozytenaggregation
JP2002355048A (ja) * 2001-05-31 2002-12-10 Communication Research Laboratory リボヌクレオチド還元酵素ｒ１とその阻害ペプチド
DE10230223A1 (de) * 2002-07-04 2004-01-22 Tegenero Ag Mikropartikel mit CD28-spezifischen monoklonalen Antikörpern
AU2003285128A1 (en) * 2002-10-31 2004-05-25 Oregon Health And Science University Use of thiol-based compositions in treating chemotherapeutic agent-induced thrombocytopenia
DE102005022319A1 (de) * 2005-05-10 2006-11-23 Symbiotec Gesellschaft Zur Forschung Und Entwicklung Auf Dem Gebiet Der Biotechnologie Mbh Verwendung von Histonen zu therapeutischen Zwecken

Also Published As

Publication number Publication date
HUE027070T2 (en) 2016-08-29
EP1879609A2 (de) 2008-01-23
CA2608019A1 (en) 2006-11-16
US8962562B2 (en) 2015-02-24
CA2811995A1 (en) 2006-11-16
KR20140137462A (ko) 2014-12-02
WO2006119912A2 (de) 2006-11-16
KR20080007351A (ko) 2008-01-18
US20140148391A1 (en) 2014-05-29
DE102005022319A1 (de) 2006-11-23
WO2006119912A3 (de) 2007-04-12
CA2608019C (en) 2013-07-02
CN101171027A (zh) 2008-04-30
JP2013151573A (ja) 2013-08-08
EP1879609B1 (de) 2014-03-12
US20150119331A1 (en) 2015-04-30
KR20130099207A (ko) 2013-09-05
ES2461564T3 (es) 2014-05-20
JP2008540473A (ja) 2008-11-20
US20090305966A1 (en) 2009-12-10
JP5667238B2 (ja) 2015-02-12
PT1879609E (pt) 2014-06-09

Similar Documents

Publication Publication Date Title
EP2026843A4 (en) THERAPEUTIC USES OF RTP801L INHIBITORS
PL3424932T3 (pl) Boronoftalidy do zastosowania terapeutycznego
GB0625659D0 (en) Therapeutic compounds and their use
IL248204A0 (en) Combined treatment of tumors expressing 38cd
IL191035A0 (en) Pharmaceutical use of substituted amides
IL191034A0 (en) Pharmaceutical use of substituted amides
PL2954932T3 (pl) Zastosowanie terapeutyczne diaminofenotiazyn
IL193747A0 (en) New therapeutic combinations for the treatment of depression
EP2049139A4 (en) TREATMENT OF TUMORS EXPRESSING RAS
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
PT1945243E (pt) Utilização da calcitonina para o tratamento da ar
GB0506835D0 (en) Therapeutic use of nefopam
DK2392335T3 (en) Use of 24-norUDCA
GB0501655D0 (en) Therapeutic use
PL1879609T3 (pl) Zastosowanie histonu w celach terapeutycznych
GB0515703D0 (en) Therapeutic use of nefopam
EP1900363A4 (en) THERAPEUTIC AGENT AGAINST PAIN
GB0623740D0 (en) Treatment of disease
GB0614538D0 (en) Therapeutic Compounds And Their Use
GB0602857D0 (en) The treatment of sialorrhoea
ZA200806180B (en) Benzoisoindole derivatives for the treatment of pain
IL195722A0 (en) Therapeutic uses of inhibitors of rtp801l
GB0625633D0 (en) Therapeutic compounds and their use
GB0518003D0 (en) Treatment of hepatatis c
GB0501657D0 (en) Therapeutic use